339 related articles for article (PubMed ID: 18376230)
1. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.
Rothenstein J; Cleary SP; Pond GR; Dale D; Gallinger S; Moore MJ; Brierley J; Siu LL
Am J Clin Oncol; 2008 Feb; 31(1):64-70. PubMed ID: 18376230
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
4. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
[TBL] [Abstract][Full Text] [Related]
6. Surgery in malignant pancreatic neuroendocrine tumors.
Nguyen SQ; Angel LP; Divino CM; Schluender S; Warner RR
J Surg Oncol; 2007 Oct; 96(5):397-403. PubMed ID: 17469119
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of small cell neuroendocrine carcinoma of the head and neck].
Li ZJ; Li HZ; Liu WS; Xu ZG; Tang PZ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3275-8. PubMed ID: 19159554
[TBL] [Abstract][Full Text] [Related]
8. The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors.
Lim E; Yap YK; De Stavola BL; Nicholson AG; Goldstraw P
J Thorac Cardiovasc Surg; 2005 Oct; 130(4):969-72. PubMed ID: 16214506
[TBL] [Abstract][Full Text] [Related]
9. [Management of nonfunctioning islet cell tumors of the pancreas].
Liang H; Wang XN; Wang BG; Pan Y; Ding XW; Hao XS
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):457-60. PubMed ID: 17974283
[TBL] [Abstract][Full Text] [Related]
10. Proposed staging system for gastrointestinal carcinoid tumors.
Landry CS; McMasters KM; Scoggins CR; Martin RC
Am Surg; 2008 May; 74(5):418-22. PubMed ID: 18481499
[TBL] [Abstract][Full Text] [Related]
11. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
12. Postirradiated neuroendocrine carcinoma of the sinonasal tract.
Wang CP; Hsieh CY; Chang YL; Lou PJ; Yang TL; Ting LL; Ko JY
Laryngoscope; 2008 May; 118(5):804-9. PubMed ID: 18520182
[TBL] [Abstract][Full Text] [Related]
13. Gut neuroendocrine tumors.
Warner RR
Curr Ther Endocrinol Metab; 1997; 6():606-14. PubMed ID: 9174816
[No Abstract] [Full Text] [Related]
14. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
Landry CS; Scoggins CR; McMasters KM; Martin RC
J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
[TBL] [Abstract][Full Text] [Related]
15. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
16. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
[TBL] [Abstract][Full Text] [Related]
17. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
18. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
19. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
Modlin IM; Champaneria MC; Chan AK; Kidd M
Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL
J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]